|
|
|
| home > pmps > spring 2004 > using technological advances to simplify cold chain monitoring procedures |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Using Technological Advances to Simplify Cold Chain Monitoring ProceduresWith pharmaceutical manufacturers and distributors having to meet the challenges and expense of cold chain distribution under increasingly stringent and far reaching regulations, it's not surprising that there's so much attention being given to the topic within the industry. And yet the Medicines and Healthcare Products Regulatory Agency (MHRA) continues to report worrying figures - 52 per cent of all critical and major deficiencies recorded by the MHRA's good distributions practice (GDP) inspectors during 2002/2003 related to the control and monitoring of storage and transportation temperatures. This represents an increase of 18 per cent over 2001/2002 figures. So where is the industry going wrong? Part of the problem seems to be industry guidance, or rather the lack thereof. While the pharmaceutical industry is well regulated and legislated, in this area at least there is a lack of accepted methodology; we know we need to comply with certain regulations, but how do we go about doing it?
The Case for Routine Temperature Monitoring
Already a sea-change can be seen with the widespread adoption of routine shipment monitoring. To date, many manufacturers or distributors have validated their distribution chain but stopped short of measuring the temperature of each shipment. Why bother? While validation of the cold chain is required, it does not in itself guarantee compliant shipments, as there is no verification that parameters remain within the validated limits. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
World Vaccine Congress
10-12 April 2012, Gaylord National Hotel and Convention Center, Washington, US
The 12th annual World Vaccine Congress Washington brings new scientific and business critical debate, discussion and solutions from the true global pioneers shaping vaccine R&D.
More info >> |
|
 |
News and Press Releases |
 |
Prism Ideas and dMetrics Launch Pioneering Service Analysing Patient–Reported Action, Behaviours and Outcomes with Social Media
Prism Ideas, the multi-national medical marketing and drug development consultants, today announced its collaboration with dMetrics, experts in identifying decisions made by millions of patients online, to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms and response to treatment.
More info >> |
|
|
